Risk Factors for 30-Day Mortality in Nosocomial Enterococcal Bloodstream Infections
Antibiotics · 27.06.2024 · 13 (7) · 601
DOI: 10.3390/antibiotics13070601 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 27.06.2024. Verfasst von Verena Zerbato und 11 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Unit, Trieste University Hospital (ASUGI), 34125 Trieste, Italy. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Enterococci commonly cause nosocomial bloodstream infections (BSIs), and the global incidence of vancomycin-resistant enterococci (VRE) BSIs is rising. This study aimed to assess the risk factors for enterococcal BSIs and 30-day mortality, stratified by Enterococcus species, vancomycin resistance, and treatment appropriateness. We conducted a retrospective cohort study (2014–2021) including all hospitalized adult patients with at least one blood culture positive for Enterococcus faecalis or Enterococcus faecium. We included 584 patients with enterococcal BSI: 93 were attributed to vancomycin-resistant E. faecium. The overall 30-day mortality was 27.5%; higher in cases of BSI due to vancomycin-resistant E. faecium (36.6%) and vancomycin-sensitive E. faecium (31.8%) compared to E. faecalis BSIs (23.2%) (p = 0.016). This result was confirmed by multivariable Cox analysis. Independent predictors of increased mortality included the PITT score, complicated bacteremia, and age (HR = 1.269, p < 0.001; HR = 1.818, p < 0.001; HR = 1.022, p = 0.005, respectively). Conversely, male gender, consultation with infectious disease (ID) specialists, and appropriate treatment were associated with reduced mortality (HR = 0.666, p = 0.014; HR = 0.504, p < 0.001; HR = 0.682, p = 0.026, respectively). In conclusion, vancomycin-resistant E. faecium bacteremia is independently associated with a higher risk of 30-day mortality.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Infectious Diseases Unit, Trieste University Hospital (ASUGI), 34125 Trieste, Italy.
- Clinical Department of Medical, Surgical and Health Sciences, Trieste University, 34129 Trieste, Italy.
- Sports and Exercise Medicine Division, Department of Medicine, University of Padova, 35128 Padua, Italy.
- Medical Emergency Service, Trieste University Hospital (ASUGI), 34125 Trieste, Italy.
- Department of Health Science, Section of Anaesthesiology and Intensive Care, University of Florence, 50139 Florence, Italy.
- Microbiology Unit, Trieste University Hospital (ASUGI), 34125 Trieste, Italy.
ORCID-Profile: Verena Zerbato, Gianfranco Sanson, Marina Busetti, Dan Alexandru Toc, Lory Saveria Crocè, Roberto Luzzati, Stefano Di Bella
Zitieren
APA
Zerbato, V., Pol, R., Sanson, G., Suru, D. A., Pin, E., Tabolli, V., Monticelli, J., Busetti, M., Toc, D. A., Crocè, L. S., Luzzati, R., & Di Bella, S. (2024). Risk Factors for 30-Day Mortality in Nosocomial Enterococcal Bloodstream Infections. Antibiotics, 13(7), 601. https://doi.org/10.3390/antibiotics13070601
Vancouver
Zerbato V, Pol R, Sanson G, Suru DA, Pin E, Tabolli V, et al. Risk Factors for 30-Day Mortality in Nosocomial Enterococcal Bloodstream Infections. Antibiotics. 2024;13(7):601. doi:10.3390/antibiotics13070601
BibTeX
@article{Zerbato2024,
author = {Zerbato, Verena and Pol, Riccardo and Sanson, Gianfranco and Suru, Daniel Alexandru and Pin, Eugenio and Tabolli, Vanessa and Monticelli, Jacopo and Busetti, Marina and Toc, Dan Alexandru and Crocè, Lory Saveria and Luzzati, Roberto and Di Bella, Stefano},
title = {Risk Factors for 30-Day Mortality in Nosocomial Enterococcal Bloodstream Infections},
journal = {Antibiotics},
year = {2024},
volume = {13},
number = {7},
pages = {601},
doi = {10.3390/antibiotics13070601}
}
EUVIMED